Health News

Fibromyalgia Linked to Sleep Problems
You toss and turn in the middle of the night. You wake up and can't fall back to sleep. As if that weren't bad enough, your sleeping problems may be putting you at risk for fibromyalgia.
Abnormal Heart Rhythm Drug Increases Risk of Dying
A drug that aids patients with intermittent atrial fibrillation, a common heart arrhythmia, increased the risk of death among patients with permanent atrial fibrillation. As a result the study was halted early.
Oral Contraceptives Linked to Prostate Cancer
The female hormone estrogen plays a role in a number of cancers, most notably breast cancer. A new study suggests that estrogen getting into public water supplies may be increasing the risk of a common male cancer.
Hiding in Plain Sight - Old Drug, New Use
Finding new uses for existing drugs has taken on new emphasis of late. With advanced technology making it easier to test for "new" benefits in existing drugs, medical researchers may have hit a home run with an old antibiotic.
Apixaban Fails to Reduce Blood Clots
An experimental drug designed to aid severely ill patients after hospitalization is not more effective than standard treatments for reducing the risk of blood clots, a study has confirmed.
Breast Cancer to Blame for Brain Blanks
Cancer patients often blame mental blanks on what they kiddingly - or seriously - refer to as "chemo brain." New evidence suggests that for breast cancer survivors, the condition is very real.
Food for Kidneys: What's Good and Bad?
With all the information out there these days, it can be hard to know which foods are good for you and which you should avoid. If you have kidney disease, your diet becomes even harder to manage.
Scientific Schizophrenic Insight
For years mental experts have questioned the impact of genetics in schizophrenia. Recent studies shed some light on a prospective source.
Sanofi, Regeneron Make Strides With Cholesterol Drug
Sanofi and Regeneron Pharmaceuticals, Inc. announced positive preliminary results from the Phase 2 study program in which patients with elevated low-density lipoprotein cholesterol (LDL-C) were treated with REGN727/SAR236553.
FDA approves Erbitux to treat late-stage head and neck cancer
The U.S. Food and Drug Administration today approved Erbitux ( cetuximab ) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.